药品集中招标采购存在问题研究

A study on the status of nosocomial medcine bidding and purchasing

文章对药品集中招标采购政策运行过程中出现的主体错位、环节增加,药品价格下降而患者药品支出下降不明显等问题进行了详细的阐述,并着重分析了产生的原因:1.集中招标采购的药品比例偏低;2.中标药品在医疗机构的使用比例偏低;3.药品生产企业、经营企业恶意竞标不能保证供应。最后针对药品集中招标采购问题提出了统筹考虑医药卫生改革、完善药品价格形成机制、建立药品招标采购信用体系、充分发挥招标代理机构的作用等对策建议。

This article aims to analyze the detail status and problems that appeared among the centralized medcine purchasing and bidding, of which principle part's misplacing and process increasing during the policy of nosocomial operations. The author also emphatically analyzed the reason as the medicine price descending, while the patient charges for medicine still not descend obviously, and the reasons were classified into 3 aspects: 1. The proportion of medicines were small in the centralized purchasing and inviting bids. 2. The proportion of tendered medicines were in low that brought shortage of nosocomial medcine. 3. Pharmaceutical Enterprises hostilely bid while could not guarantee the supply. Aiming at the problems caused by the Concentrate bidding for medicines purchasing ,the article suggested: considering the medical and health reform and the perfectness of the medicines price form mechanism as a whole,we should set up a credit system of the bid for medicines purchase , fully exert the role of bid agency and so on.